Key result
Combination antihypertensives outperform monotherapy for BP control via multiple mechanisms and lower drug doses.
Why the study?
Raised blood pressure is a common complication linked to atherosclerosis and ischemic heart disease, warranting an overview of monotherapy versus multi-mechanism combination therapy approaches.
Does combination antihypertensive therapy improve blood pressure management and reduce cardiovascular disease risks compared to monotherapy in patients with hypertension?
Comparison
Combination therapy vs monotherapy
Design
Review
Authors
Loading...
Supports mechanistic advantages of combination therapy; leaves open impact on cardiovascular outcomes from RCTs.
Does combination antihypertensive therapy improve blood pressure management and reduce cardiovascular disease risks compared to monotherapy in patients with hypertension?
Combination antihypertensive therapy offers mechanistic advantages and requires lower drug doses compared to monotherapy for effective blood pressure management.
Niranjan et al. (2023) conducted a review in Hypertension. Combination antihypertensive therapy vs. Monotherapy was evaluated. Combination antihypertensive therapy provides advantages over monotherapy by acting via multiple mechanisms and requiring minimal drug amounts to manage elevated blood pressure effectively.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: